Print

Stentys Reports Stronger Operational Performance During First Half of 2012 Versus Prior Year  
8/30/2012 3:30:02 PM

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), today reports its half-year results for the six months to 30 June 2012, approved at the Board of Directors meeting on 30 August 2012.
//-->